<DOC>
	<DOCNO>NCT00700934</DOCNO>
	<brief_summary>The aim study describe natural history patient alpha-1 antitrypsin associate emphysema figure associate prognostic factor .</brief_summary>
	<brief_title>Management Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema</brief_title>
	<detailed_description>All patient suffer disease follow every 6 month 5 year period . FEV1 decline primary endpoint . Quality life assess use Saint George 's Respiratory Questionary record .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>Serum alpha one antitrypsin &lt; 0.8 g/l Emphysema diagnose CT scan Adult Obstructive disorder Liver lung transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>FEV1</keyword>
	<keyword>mortality</keyword>
	<keyword>Quality life</keyword>
</DOC>